Gesamtpreis (1 Artikel Artikel):
Versandziel:
nandave (148 Ergebnisse)
Direkt zu den wichtigsten Suchergebnissen
Suchfilter
Produktart
- Alle Product Types
- Bücher (148)
- Magazine & Zeitschriften (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Comics (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Noten (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Kunst, Grafik & Poster (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Fotografien (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Karten (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Manuskripte & Papierantiquitäten (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
Zustand Mehr dazu
- Neu (144)
- Wie Neu, Sehr Gut oder Gut Bis Sehr Gut (4)
- Gut oder Befriedigend (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Ausreichend oder Schlecht (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Wie beschrieben (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
Weitere Eigenschaften
- Erstausgabe (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Signiert (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Schutzumschlag (Keine weiteren Ergebnisse entsprechen dieser Verfeinerung)
- Angebotsfoto (52)
- Keine Print-on-Demand Angebote (76)
Sprache (1)
Gratisversand
Land des Verkäufers
Verkäuferbewertung
-
Angiotensin converting Enzyme Inhibitors vs Angiotensin Receptor Blockers (eng)
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Verkäuferbewertung 3 von 5 Sternen
Zustand: new.
-
Immunity to Immunotherapy in Cancer (Paperback)
Sprache: Englisch
Verlag: Elsevier Science Publishing Co Inc, San Diego, 2026
ISBN 10: 044341551X ISBN 13: 9780443415517
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Verkäuferbewertung 5 von 5 Sternen
Paperback. Zustand: new. Paperback. Immunity to Immunotherapy in Cancer Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
-
Immunity to Immunotherapy in Cancer: Mechanisms and Limitations
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Verkäuferbewertung 4 von 5 Sternen
EUR 158,15
EUR 7,50 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 3 verfügbar
In den WarenkorbZustand: New.
-
-
Immunity to Immunotherapy in Cancer: Mechanisms and Limitations
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 160,39
EUR 17,31 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 330 pages. 7.52x1.34x9.25 inches. In Stock.
-
Angiotensin converting Enzyme Inhibitors vs Angiotensin Receptor Blockers (eng)
Anbieter: Brook Bookstore, Milano, MI, Italien
Verkäuferbewertung 4 von 5 Sternen
Zustand: new.
-
Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers (Hardcover)
Sprache: Englisch
Verlag: Springer Verlag, Singapore, Singapore, 2024
ISBN 10: 9819773792 ISBN 13: 9789819773794
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Verkäuferbewertung 5 von 5 Sternen
Hardcover. Zustand: new. Hardcover. This book delves into the various aspects of the renin-angiotensin-aldosterone system (RAAS) and its role in cardiovascular disorders. It explores the use of anti-hypertensive agents, with a focus on (ACE) angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Additionally, the book examines the role of ACE inhibitors and ARBs in COVID-19 patients and provides insights into recent trends in managing hypertension through RAAS inhibition. It serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in the field of cardiovascular medicine. The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
-
Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers: A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 166,38
EUR 17,31 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 616 pages. 9.26x6.11x9.49 inches. In Stock.
-
Mycoremediation of Xenobiotics (Hardcover)
Sprache: Englisch
Verlag: Springer Verlag, Singapore, Singapore, 2026
ISBN 10: 9819557429 ISBN 13: 9789819557424
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Verkäuferbewertung 5 von 5 Sternen
Hardcover. Zustand: new. Hardcover. This book presents a scientific exploration into the use of fungal enzymes to degrade persistent environmental pollutants. It combines foundational theory, emerging research, and real-world case studies to showcase fungis role in mitigating chemical contamination.The book begins by outlining the global threat posed by xenobioticssynthetic compounds like pesticides, pharmaceuticals, and industrial chemicalsand the limitations of conventional remediation strategies. Early chapters delve into the biology of fungi, highlighting their powerful enzymatic systems such as laccases and peroxidases. These systems underpin the mycoremediation process, offering eco-friendly alternatives for detoxifying harmful pollutants.Subsequent chapters explore fungal degradation mechanisms, including enzymatic pathways, metabolic routes, and genomic insights. Readers will find extensive coverage of bioreactor design, large-scale applications, and case studies across various environmental settings. The book also addresses the technological, regulatory, and economic challenges of implementing mycoremediation, concluding with future prospects in synthetic biology, CRISPR-engineered fungi, and policy development.This comprehensive resource is tailored for a diverse audience including environmental scientists, microbiologists, biotechnologists, engineers, policymakers, and advanced students. Whether for academic research, policy formulation, or field application, this book serves as an essential reference for those seeking sustainable solutions to the growing threat of xenobiotic contamination through fungal biotechnology. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
-
Immunity to Immunotherapy in Cancer: Mechanisms and Limitations
Sprache: Englisch
Verlag: Elsevier Science Publishing Co Inc, 2026
ISBN 10: 044341551X ISBN 13: 9780443415517
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 175,85
EUR 18,14 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbPaperback / softback. Zustand: New. New copy - Usually dispatched within 4 working days.
-
Immunity to Immunotherapy in Cancer: Mechanisms and Limitations
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Verkäuferbewertung 4 von 5 Sternen
Zustand: New.
-
Gut Health and Metabolic Syndrome (eng)
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Verkäuferbewertung 3 von 5 Sternen
Zustand: new.
-
Mycoremediation of Xenobiotics: Harnessing Fungi for Environmental Detoxification (Emerging Paradigms in Pharmaceutical Research)
Anbieter: California Books, Miami, FL, USA
Verkäuferbewertung 4 von 5 Sternen
Zustand: New.
-
Gut Health and Metabolic Syndrome (eng)
Anbieter: Brook Bookstore, Milano, MI, Italien
Verkäuferbewertung 4 von 5 Sternen
Zustand: new.
-
Immunity to Immunotherapy in Cancer: Mechanisms and Limitations
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. 2026. paperback. . . . . .
-
Zustand: New. 2024th edition NO-PA16APR2015-KAP.
-
Zustand: New. 2024th edition NO-PA16APR2015-KAP.
-
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in Heart Failure (Hardcover)
Sprache: Englisch
Verlag: Springer Verlag, Singapore, Singapore, 2024
ISBN 10: 9819775671 ISBN 13: 9789819775675
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Verkäuferbewertung 5 von 5 Sternen
Hardcover. Zustand: new. Hardcover. The book delves into the development and therapeutic potential of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors for the treatment of diabetes and cardiovascular diseases. It explores their mechanism of action, cardiovascular benefits, and role in primary and secondary protection from renal and cardiovascular diseases. The book also highlights their emerging opportunities in the management of myocardial infarction, diabetic cardiomyopathy, and congestive heart failure. It provides a comprehensive review of preclinical and clinical information on the cardiovascular advantages of SGLT2 inhibitors. Additionally, the book explores selective drugs and their effects on cardiovascular events, mortality, and safety outcomes in individuals with type 2 diabetes.The book is a valuable resource for researchers, healthcare professionals, and individuals interested in the field of SGLT2 inhibitors and their impact on diabetes and cardiovascular health. The book delves into the development and therapeutic potential of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors for the treatment of diabetes and cardiovascular diseases. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
-
Zustand: New. pp. 505.
-
Taschenbuch. Zustand: Neu. Ethnopharmacology and OMICS Advances in Medicinal Plants Volume 1 | Uncovering Diversity and Ethnopharmacological Aspects | Mukesh Nandave (u. a.) | Taschenbuch | xxiv | Englisch | 2025 | Springer | EAN 9789819723690 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Zustand: New. Provides an in-depth examination of the molecular strategies of immune evasion and the tumor microenvironment, offering critical insights into why some patients do not respond to immunotherapyBridges the gap between current research and pra.
-
Protac-mediated Protein Degradation : A Paradigm Shift in Cancer Therapeutics
Anbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
EUR 228,17
EUR 2,26 Versand
Versand innerhalb von USAAnzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
-
Zustand: New. 2024th edition NO-PA16APR2015-KAP.
-
Taschenbuch. Zustand: Neu. Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in Heart Failure | Mechanisms and Clinical Applications: A Machine-Generated Literature Overview | Mukesh Nandave | Taschenbuch | xiv | Englisch | 2025 | Springer | EAN 9789819775705 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Taschenbuch. Zustand: Neu. Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers | A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview | Mukesh Nandave | Taschenbuch | xiv | Englisch | 2025 | Springer | EAN 9789819773824 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Taschenbuch. Zustand: Neu. Pharmacovigilance Essentials | Advances, Challenges and Global Perspectives | Mukesh Nandave (u. a.) | Taschenbuch | xix | Englisch | 2025 | Springer | EAN 9789819989515 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Taschenbuch. Zustand: Neu. Ethnopharmacology and OMICS Advances in Medicinal Plants Volume 2 | Revealing the Secrets of Medicinal Plants | Mukesh Nandave (u. a.) | Taschenbuch | xxvi | Englisch | 2025 | Springer | EAN 9789819742943 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Internationale AusgabeETHNOPHARMACOLOGY AND OMICS ADVANCES IN MEDICINAL PLANTS VOLUME 1 UNCOVERING DIVERSITY AND ETHNOPHARMACOLOGICAL ASPECTS (HB 2024)
Anbieter: UK BOOKS STORE, London, LONDO, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
EUR 228,18
EUR 6,91 Versand
Versand von Vereinigtes Königreich nach USAAnzahl: 3 verfügbar
In den WarenkorbZustand: New. Brand New ! Fast Delivery "International Edition " and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 4-6 Working days .and we do have flat rate for up to 2LB. Extra shipping charges will be requested This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
-
Gut Health and Metabolic Syndrome (Hardcover)
Sprache: Englisch
Verlag: Springer Nature Switzerland AG, Cham, 2025
ISBN 10: 9819662451 ISBN 13: 9789819662456
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Verkäuferbewertung 5 von 5 Sternen
Hardcover. Zustand: new. Hardcover. This book integrates the latest advancements in biomedical science related to metabolic syndrome and microbiome research. It comprehensively covers a broad range of topics including composition and function of the gut microbiota in metabolic syndrome, mechanisms linking the gut microbiome to metabolic syndrome, dietary interventions, pharmacological approaches, exercise, lifestyle modifications, psychosocial factors, role of the gut microbiome in obesity and insulin resistance, and clinical applications and translational perspectives. Despite significant research on metabolic syndrome, its risk factors, therapeutic interventions and the role of microbiome, there is still lack of recent updates and massive efforts are required to update the information on these topics with special emphasis on potential interventions targeting the gut microbiome to mitigate metabolic syndrome risk. This book focuses on leveraging the intricate relationship between the microbiome, gut health, and metabolic syndrome, including dysbiosis, inflammation, impaired gut barrier function, mechanisms through which the gut microbiome influences metabolic syndrome including host-microbiota interactions, microbial metabolites, and immune modulation to develop innovative interventions aimed at improving overall health outcomes. The purpose of this research is to explore microbiome-based interventions that can positively influence gut ecology and mitigate the risk factors associated with metabolic syndrome. By understanding how specific dietary interventions, probiotics, prebiotics, and other microbiome-targeted therapies can modulate the gut microbiome, this work aims to develop effective strategies for optimizing gut health and metabolic function.Through interdisciplinary collaboration and cutting-edge research methodologies, this work strives to pave the way for personalized approaches to healthcare that prioritize the microbiome as a key determinant of overall health and well-being. The principal audience for this book comprises of pharmacologists, microbiologists, clinical pharmacists, and toxicologists. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
-
Zustand: New. 2024th edition NO-PA16APR2015-KAP.
